PER-053-99已完成未知
A DOUBLE BLIND, RANDOMIZED, STRATIFIED STUDY IN PARALLEL GROUPS TO EVALUATE THE INCIDENCE OF ULCERA, BLEEDING OR PERFORATIONS DURING CHRONIC TREATMENT WITH MI-0966 OR NAPROXENE IN PATIENTS WITH REUMATOID ARTHRITIS, INTERNATIONAL COHORT
MERCK SHARP & DOHME PERÚ S.R.L.,0 个研究点目标入组 0 人开始时间: 1999年2月5日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
To compare giving injection in the skin where the laproscopic ports are inserted AND Giving injection in the abdomen between the muscles FOR PAIN RELIEF IN Patients who Get sterilized using laproscopic technique.CTRI/2019/02/017372SRI RAMACHANDRA UNIVERSITY80
进行中（未招募）
不适用
A PROSPECTIVE DOUBLE BLIND AND RANDOMIZED STUDY ON THE EFFECT OF TRANDOLAPRIL, IN MAINTAINING SINUS RHYTHM IN PATIENTS WITH LONG-LASTING PERSISTENT ATRIAL FIBRILLATION.ESTUDIO PROSPECTIVO, DOBLE CIEGO, RANDOMIZADO, SOBRE EL EFECTO DE TRANDOLAPRIL EN EL MANTENIMIENTO DEL RITMO SINUSAL EN PACIENTES CON FA PERSISTENTE DE LARGA DURACIÓN.PACIENTES CON FA PERSISTENTE DE LARGA DURACÍON.EUCTR2004-002013-36-ESCONCEPCION MORO SERRANO
已完成
3 期
PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND STUDY, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTI-CENTER TRIAL ASSESSING THE EFFECTS OF BF2.649 IN TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS IN NARCOLEPSY (*HARMONY 1*)NL-OMON33230Bioprojet9
进行中（未招募）
不适用
PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND STUDY, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTI-CENTER TRIAL ASSESSING THE EFFECTS OF BF2.649 IN TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS IN NARCOLEPSY(HARMONY 1”) - Harmony IarcolepsyMedDRA version: 9.1Level: LLTClassification code 10028713Term: NarcolepsyMedDRA version: 9.1Level: LLTClassification code 10048322Term: Narcolepsy aggravatedMedDRA version: 9.1Level: LLTClassification code 10021235Term: Idiopathic narcolepsyMedDRA version: 9.1Level: LLTClassification code 10007737Term: CataplexyMedDRA version: 9.1Level: LLTClassification code 10048323Term: Cataplexy aggravatedEUCTR2008-007866-46-HUBioprojet90
进行中（未招募）
3 期
CLINICAL STUDY, DOUBLE-BLIND, RANDOMIZED TO EVALUATE THE EFFICACY AND SAFETY OF SODIUM PICOSULPHATE 2.5MG /100ML (CALORIE-FREE MARKOS PURGANT LEMONADE), PLACEBO CONTROLLED IN PATIENTS WITH FUNCTIONAL CHRONIC CONSTIPATIOK599 Functional intestinal disorder, unspecifiedFunctional intestinal disorder, unspecifiedK599PER-006-21ABORATORIOS FARMACEUTICOS MARKOS S.A276